glp-1/gip/glucagon receptor agonist The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Glucagon-like peptide-1 - Wikipedia

Liraglutide promotes cortical neurite outgrowth via the MEK-ERK pathway

Importantly, GLP1 receptor agonists offer the potential to serve as a glidepath for individuals who have struggled to get started with behavioral modification due to preexisting overweight or obesity

Semaglutide and cardiovascular outcomes in obesity without diabetes

One of the advantages Holst's group had in working on the issue was that researchers in Copenhagen were skilled at keeping pancreases alive that had been removed from pigs by perfusion with artificial blood

doi: 10.2337/dc14-1958 209 GallwitzBVaagAFalahatiAMadsbadS

Exenatide treatment was associated with a prolonged increase of phosphorylation of insulin receptor signaling substrate-1 (IRS1) phosphorylated at tyrosine residues at 24, 48, and 60 weeks